LifeStance Health Group (NASDAQ:LFST) Raised to Strong-Buy at Wall Street Zen

LifeStance Health Group (NASDAQ:LFST – Get Free Report) was upgraded by investment analysts at Wall Street Zen from a “buy” rating to a “strong-buy” rating in a research report issued to clients and investors on Saturday, Wall Street Zen reports.

Several other equities analysts have also commented on the stock. BTIG Research upped their price target on shares of LifeStance Health Group from $18.00 to $20.00 and gave the stock a “buy” rating in a research report on Thursday, November 5th. Canaccord Genuity Group lifted their price objective on shares of LifeStance Health Group from $15.00 to $16.00 and gave the company a “buy” rating in a research report on Friday, November 6th. KeyCorp lifted their price objective on shares of LifeStance Health Group from $15.00 to $17.00 and gave the company an “overweight” rating in a research report on Friday, November 6th. Barclays boosted their target price on shares of LifeStance Health Group from $13.00 to $15.00 and gave the company an “overweight” rating in a research note on Thursday, September 10th. Finally, JPMorgan Chase & Co. boosted their target price on shares of LifeStance Health Group from $13.00 to $15.00 and gave the company a “neutral” rating in a research note on Thursday. One research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and four have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, LifeStance Health Group has an average rating of “Moderate Buy” and an average target price of $14.86.

Check Out Our Latest Report on LifeStance Health Group

LifeStance Health Group Price Performance

Shares of NASDAQ LFST opened at $14.08 on Friday. LifeStance Health Group has a 1-year low of $6.01 and a 1-year high of $15.66. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.44 and a quick ratio of 1.44. The business’s fifty day moving average price is $12.79 and its two-hundred day moving average price is $9.67. The firm has a market capitalization of $5.35 billion, a PE ratio of 74.11 and a beta of 1.35.

LifeStance Health Group (NASDAQ:LFST – Get Free Report) last posted its earnings results on Thursday, November 5th. The company reported $0.06 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.04 by $0.02. LifeStance Health Group had a return on equity of 4.82% and a net margin of 4.29%. The company had revenue of $455.86 million for the quarter, compared to analysts’ expectations of $431.59 million. LifeStance Health Group’s revenue was up 25.3% compared to the same quarter last year. On average, research analysts expect that LifeStance Health Group will post 0.18 EPS for the current year.

Insider Activity at LifeStance Health Group

In other LifeStance Health Group news, insider Ryan Pardo sold 2,216,585 shares of the business’s stock in a transaction on Tuesday, November 10th. The stock was sold at an average price of $14.58, for a total transaction of $32,317,809.30. Following the completion of the transaction, the insider owned 334,935 shares in the company, valued at approximately $4,883,352.30. The trade was a 86.87% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, COO Lisa K. Miller sold 14,663 shares of the business’s stock in a transaction on Wednesday, November 11th. The stock was sold at an average price of $14.68, for a total value of $215,252.84. Following the transaction, the chief operating officer owned 251,904 shares of the company’s stock, valued at $3,697,950.72. This trade represents a 5.50% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 2,861,235 shares of company stock worth $41,646,338 in the last three months. 3.50% of the stock is owned by company insiders.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the business. BlackRock Inc. acquired a new stake in LifeStance Health Group in the second quarter worth about $389,293,000. Marshall Wace LLP grew its position in LifeStance Health Group by 511.8% in the 3rd quarter. Marshall Wace LLP now owns 9,955,435 shares of the company’s stock valued at $119,764,000 after buying an additional 8,328,169 shares in the last quarter. Dimensional Fund Advisors LP grew its position in LifeStance Health Group by 16.4% in the 1st quarter. Dimensional Fund Advisors LP now owns 10,367,680 shares of the company’s stock valued at $66,038,000 after buying an additional 1,461,215 shares in the last quarter. Jennison Associates LLC grew its position in LifeStance Health Group by 38.5% in the 1st quarter. Jennison Associates LLC now owns 10,228,801 shares of the company’s stock valued at $65,157,000 after buying an additional 2,843,388 shares in the last quarter. Finally, Voya Investment Management LLC increased its stake in LifeStance Health Group by 1,249.6% during the 3rd quarter. Voya Investment Management LLC now owns 3,971,989 shares of the company’s stock valued at $47,783,000 after buying an additional 3,677,679 shares during the period. 85.50% of the stock is owned by institutional investors and hedge funds.

About LifeStance Health Group

(Get Free Report)

LifeStance Health Group, Inc. is a U.S. provider of outpatient mental health services. The company offers care through in-person clinics and virtual appointments, connecting patients with behavioral health professionals. Its services include psychotherapy, psychiatric evaluations and medication management. LifeStance’s clinicians treat a range of mental health conditions, including anxiety, depression, attention-deficit/hyperactivity disorder and mood disorders. Founded in 2017, LifeStance has expanded its network across the United States.

Further Reading

Analyst Recommendations for LifeStance Health Group (NASDAQ:LFST)

Receive News & Ratings for LifeStance Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeStance Health Group and related companies with MarketBeat.com's FREE daily email newsletter.